captopril has been researched along with Obesity in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.41) | 18.7374 |
| 1990's | 12 (44.44) | 18.2507 |
| 2000's | 5 (18.52) | 29.6817 |
| 2010's | 4 (14.81) | 24.3611 |
| 2020's | 4 (14.81) | 2.80 |
| Authors | Studies |
|---|---|
| Guimarães, JPT; Jancar, S; Kalupahana, NS; Martins, JO; Menikdiwela, KR; Moustaid-Moussa, N; Queiroz, LAD; Ramalho, T; Ramalingam, L | 1 |
| Alexandra, PTAA; Cheng, HS; Goh, BH; Palanisamy, UD; Tan, JBL; Ting, KN | 1 |
| Kravchun, PG; Martovytskyi, DV; Shelest, OM | 1 |
| Cho, JM; Fu, Z; Hu, J; Liu, X; Lu, A; Lu, X; Su, J; Symons, JD; Wang, F; Yang, T; Zou, CJ | 1 |
| de Kloet, AD; Kim, DH; Krause, EG; Sakai, RR; Seeley, RJ; Woods, SC | 1 |
| Begg, DP; Cameron-Smith, D; Hafandi, A; Jois, M; Manickam, E; Premaratna, SD; Rayment, DJ; Weisinger, RS | 1 |
| Kochi, T; Kubota, M; Moriwaki, H; Ohno, T; Sakai, H; Shimizu, M; Tanaka, T; Tsurumi, H; Yasuda, Y | 1 |
| Ailhaud, G; Kalupahana, NS; Massiera, F; Moustaid-Moussa, N; Quignard-Boulange, A; Voy, BH; Wasserman, DH | 1 |
| Forman, JP; Larson, C; Sun, B; Vaidya, A; Williams, JS | 1 |
| Arbin, V; Claperon, N; Fournié-Zaluski, MC; Peyroux, J; Roques, BP | 1 |
| Kost, CK; Likness, MM; Schlenker, EH | 1 |
| Albuquerque, Mde F; Lima, SG; Nascimento, LS; Santos Filho, CN; Victor, EG | 1 |
| Abel, ED; Buchanan, J; Cooksey, RC; Tabbi-Anneni, I | 1 |
| Drayer, JI; Weber, MA | 1 |
| Anthanázio-Heliodoro, Rde C; Brandão-Neto, J; de Barros e Silva, M; Franco RJ da, S; Marchioli, M; Martin, LC; Velasco-Cornejo, IF | 1 |
| Andrés, A; Hernández, E; León, M; Praga, M; Rodicio, JL; Ruilope, LM | 1 |
| Henriksen, EJ; Jacob, S | 1 |
| Boucher, L; Cozic, JA; Gorlier, R; Huin, P; Pettenuzzo-Mollo, M; Provendier, O; Raccah, D; Sicard, J; Vague, P | 1 |
| Cuesta, C; Martínez, J; Robles, RG; Ruilope, LM; Sancho, JM; Santirso, R; Villa, E | 1 |
| Zhao, D | 1 |
| Amy, RM; Dolphin, PJ; Graham, SE; Russell, JC | 1 |
| Albarrán, OG; García-Robles, R; Rábano, A; Ruilope, LM; Villa, E | 1 |
| Dal Ponte, DB; Fogt, DL; Henriksen, EJ; Jacob, S | 1 |
| Brenelli, SL; Carvalho, CR; Carvalho, DS; Saad, MJ; Villaça, V | 1 |
| Barzizza, F; Crea, G; Magnani, L; Richichi, I | 1 |
| Jung, CY; Lachaal, M | 1 |
| Leblanc, H; Marre, M; Passa, P | 1 |
1 review(s) available for captopril and Obesity
| Article | Year |
|---|---|
Insulin resistance and hypertension.
Topics: Adipose Tissue; Animals; Captopril; Catecholamines; Disease Models, Animal; Fructose; Glucose Tolerance Test; Humans; Hypertension; Insulin; Insulin Resistance; Lipolysis; Monosaccharide Transport Proteins; Obesity; Prazosin; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY | 1992 |
5 trial(s) available for captopril and Obesity
| Article | Year |
|---|---|
Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cholecalciferol; Drug Resistance; Drug Synergism; Female; Humans; Hypertension; Male; Middle Aged; Obesity; Renal Plasma Flow; Vitamin D Deficiency | 2012 |
[Systemic hypertension at emergency units. The use of symptomatic drugs as choice for management].
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure Determination; Captopril; Diazepam; Dipyrone; Emergency Treatment; Female; Headache; Humans; Hypertension; Male; Middle Aged; Obesity; Patient Compliance; Treatment Outcome | 2005 |
[Arterial hypertension in obese patients with heart hypertrophy. Effects of captopril on insulin sensitivity and growth hormone].
Topics: Adult; Aged; Antihypertensive Agents; Blood Glucose; Captopril; Female; Glucose Intolerance; Glucose Tolerance Test; Growth Hormone; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin; Insulin Resistance; Lipids; Male; Middle Aged; Obesity; Time Factors | 1995 |
Effects of body-weight loss and captopril treatment on proteinuria associated with obesity.
Topics: Adult; Aged; Blood Pressure; Captopril; Creatinine; Female; Humans; Male; Middle Aged; Obesity; Prospective Studies; Proteinuria; Treatment Outcome; Weight Loss | 1995 |
Comparison of the effects of captopril and nicardipine on insulin sensitivity and thrombotic profile in patients with hypertension and android obesity. CaptISM Study Group. Captopril Insulin Sensitivity Multicenter Study Group.
Topics: Adult; Aged; Antigens; Blood Pressure; Captopril; Double-Blind Method; Factor VII; Female; Fibrinogen; Glucose Tolerance Test; Humans; Hypertension; Insulin; Insulin Resistance; Lipids; Male; Middle Aged; Nicardipine; Obesity; Radioimmunoassay; Risk Factors | 1994 |
21 other study(ies) available for captopril and Obesity
| Article | Year |
|---|---|
Effects of captopril on glucose metabolism and autophagy in liver and muscle from mice with type 1 diabetes and diet-induced obesity.
Topics: Animals; Autophagy; Beclin-1; Captopril; Diabetes Mellitus, Type 1; Diet; Glucose; Liver; Mice; Mice, Obese; Muscles; Obesity; RNA, Messenger | 2022 |
Geraniin Ameliorates Hypertensive Vascular Remodelling in a Diet-Induced Obese Animal Model through Antioxidant and Anti-Inflammatory Effects.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Captopril; Diet, High-Fat; Hydrolyzable Tannins; Hypertension; Male; Models, Animal; Obesity; Oxidative Stress; Rats; Rats, Sprague-Dawley; Vascular Remodeling | 2023 |
Effect of endostatin and insulin-like growth factor-1 on angiogenesis in patients with acute myocardial infarction with obesity under the influence of zofenopril.
Topics: Captopril; Endostatins; Humans; Insulin-Like Growth Factor I; Myocardial Infarction; Obesity | 2020 |
Soluble (pro)renin receptor induces endothelial dysfunction and hypertension in mice with diet-induced obesity via activation of angiotensin II type 1 receptor.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Diet, High-Fat; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Hypertension; Losartan; Male; Mice; Mice, Inbred C57BL; Obesity; Prorenin Receptor; Receptor, Angiotensin, Type 1; Receptors, Cell Surface; Renin-Angiotensin System | 2021 |
The effect of angiotensin-converting enzyme inhibition using captopril on energy balance and glucose homeostasis.
Topics: Adipose Tissue; Administration, Oral; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Captopril; Dietary Fats; Eating; Energy Metabolism; Glucose; Injections, Intraventricular; Injections, Subcutaneous; Male; Neuropeptide Y; Obesity; Peptidyl-Dipeptidase A; Rats; Rats, Long-Evans; Renin; RNA, Messenger | 2009 |
Angiotensin-converting enzyme inhibition reverses diet-induced obesity, insulin resistance and inflammation in C57BL/6J mice.
Topics: Acyl-CoA Dehydrogenase, Long-Chain; Adiponectin; Adipose Tissue; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Body Weight; Captopril; Chemokine CCL2; Diet, High-Fat; Gene Expression Regulation; Glucose Tolerance Test; Inflammation; Insulin Resistance; Interleukin-6; Ion Channels; Leptin; Lipid Metabolism; Lipoprotein Lipase; Male; Mice; Mice, Inbred C57BL; Mitochondrial Proteins; Muscle, Skeletal; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Sterol Esterase; Toll-Like Receptor 4; Trans-Activators; Transcription Factors; Uncoupling Protein 2 | 2012 |
Renin-angiotensin system inhibitors suppress azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Azoxymethane; Benzimidazoles; Benzoates; Captopril; Colonic Neoplasms; Cyclooxygenase 2; Deoxyguanosine; Interleukin-1beta; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Obesity; Oxidative Stress; Plasminogen Activator Inhibitor 1; Precancerous Conditions; Renin-Angiotensin System; RNA, Messenger; Telmisartan; Tumor Necrosis Factor-alpha | 2011 |
Overproduction of angiotensinogen from adipose tissue induces adipose inflammation, glucose intolerance, and insulin resistance.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Captopril; Glucose Intolerance; Glycerolphosphate Dehydrogenase; Inflammation; Insulin Resistance; Interleukin-10; Male; Mice; Muscle, Skeletal; NF-kappa B; Obesity; Up-Regulation | 2012 |
Effects of dual angiotensin-converting enzyme and neutral endopeptidase 24-11 chronic inhibition by mixanpril on insulin sensitivity in lean and obese Zucker rats.
Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Flow Velocity; Blood Glucose; Captopril; Drug Therapy, Combination; Insulin; Male; Neprilysin; Obesity; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Rats, Zucker; Thinness | 2003 |
Effects of long-term captopril and L-arginine treatment on ventilation and blood pressure in obese male SHHF rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Blood Pressure; Captopril; Hypertension, Pulmonary; Hypoventilation; Male; Obesity; Oxygen Consumption; Pulmonary Ventilation; Rats; Treatment Outcome | 2004 |
Captopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse hearts.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Body Weight; Captopril; Cardiovascular Diseases; Drug Evaluation, Preclinical; Glucose; Heart; Insulin; Insulin Resistance; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Myocardium; Obesity; Organ Culture Techniques; Organ Size; Oxygen Consumption; Signal Transduction | 2008 |
Severe hypertension: special problems in the elderly.
Topics: Acute Disease; Administration, Oral; Age Factors; Aged; Antihypertensive Agents; Blood Pressure; Brain Diseases; Captopril; Cardiovascular Diseases; Diuretics; Humans; Hypertension; Hypertension, Renovascular; Kidney Diseases; Middle Aged; Obesity; Patient Compliance | 1983 |
Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats.
Topics: Animals; Biological Transport; Body Weight; Captopril; Female; Glucose; In Vitro Techniques; Insulin; Muscle Contraction; Muscle, Skeletal; Obesity; Organ Size; Rats; Rats, Zucker | 1995 |
Effects of captopril on sympathetic activity, lipid and carbohydrate metabolism in a model of obesity-induced hypertension in dogs.
Topics: Animals; Blood Glucose; Captopril; Carbohydrate Metabolism; Cholesterol; Dogs; Hemodynamics; Hypertension; Kidney; Lipid Metabolism; Norepinephrine; Obesity; Sympathetic Nervous System | 1993 |
[A preliminary study of insulin resistance in essential hypertension, simple obesity and acromegaly].
Topics: Acromegaly; Adult; Blood Glucose; Captopril; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hyperinsulinism; Hypertension; Insulin; Insulin Resistance; Male; Middle Aged; Obesity | 1993 |
Inhibition of myocardial lesions in the JCR:LA-corpulent rat by captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Arteriosclerosis; Captopril; Male; Microscopy, Electron, Scanning; Myocardial Ischemia; Myocardium; Obesity; Rats; Rats, Mutant Strains | 1998 |
Effects of chronic combined treatment with captopril and pravastatin on the progression of insulin resistance and cardiovascular alterations in an experimental model of obesity in dogs.
Topics: Animals; Anticholesteremic Agents; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Captopril; Cardiovascular Diseases; Cholesterol; Coronary Vessels; Disease Models, Animal; Disease Progression; Dogs; Drug Therapy, Combination; Heart; Insulin; Insulin Resistance; Linear Models; Male; Multivariate Analysis; Myocardium; Obesity; Pravastatin; Triglycerides | 1998 |
Interactions of captopril and verapamil on glucose tolerance and insulin action in an animal model of insulin resistance.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Calcium Channel Blockers; Captopril; Disease Models, Animal; Drug Interactions; Female; Glucose; Glucose Tolerance Test; Glucose Transporter Type 4; Insulin; Insulin Resistance; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Obesity; Oxidation-Reduction; Phosphorylation; Rats; Rats, Zucker; Verapamil | 1998 |
Angiotensin-converting enzyme inhibitor increases insulin-induced pp185 phosphorylation in liver and muscle of obese rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Insulin; Insulin Receptor Substrate Proteins; Intracellular Signaling Peptides and Proteins; Liver; Male; Muscle, Skeletal; Obesity; Phosphoproteins; Phosphorylation; Phosphotyrosine; Rats; Rats, Wistar; Receptor, Insulin | 1998 |
[Regression of left ventricular hypertrophy in obese hypertensive patients treated with diet and pharmacologic therapy].
Topics: Captopril; Female; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Obesity; Remission Induction | 1992 |
[Treatment of arterial hypertension in diabetics. Contribution of converting enzyme inhibitors].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diuretics; Enalapril; Humans; Hypertension; Obesity; Vasodilator Agents | 1985 |